Business Context and Reporting Period
This Form 8-K Current Report was filed by Viking Therapeutics, Inc. on June 7, 2018. The filing discloses the entry into a material definitive agreement regarding an underwritten public offering of the Company's common stock.
Key Financial Metrics and Transaction Details
- Offering Size: 7,500,000 shares of Common Stock.
- Public Offering Price: $9.00 per share.
- Underwriter Purchase Price: $8.415 per share.
- Over-Allotment Option: Underwriters granted an option to purchase up to an additional 1,125,000 shares within 30 days.
- Expected Gross Proceeds: Approximately $67.5 million (excluding over-allotment and before deducting underwriting discounts and expenses).
- Expected Closing Date: On or about June 11, 2018.
Material Changes and Agreements
The primary material change is the execution of an Underwriting Agreement with William Blair & Company, L.L.C. as the representative. The agreement includes customary representations, warranties, indemnification provisions, and termination clauses. Additionally, the Company's directors and executive officers have entered into "lock-up" agreements prohibiting the sale or transfer of Company securities until September 5, 2018, without prior written consent.
Guidance, Risks, and Contingencies
The filing contains forward-looking statements regarding the anticipated closing of the Offering and expected proceeds. Key risks and contingencies include:
- The ability to satisfy customary closing conditions on a timely basis or at all.
- Market conditions affecting the transaction.
- The Company explicitly states it does not intend to revise or update forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the final closing date and actual gross proceeds received after deducting underwriting discounts and commissions.
- Confirm whether the underwriters exercised the over-allotment option for the additional 1,125,000 shares.
- Review the Company's periodic reports for updated liquidity positions and cash burn rates post-offering.
- Monitor compliance with the lock-up agreement expiration on September 5, 2018.